VOLU SOL INC
NT 10-Q, 2000-08-15
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: AMB PROPERTY LP, 8-K, EX-3.1, 2000-08-15
Next: SUMMIT BROKERAGE SERVICES INC / FL, 10QSB/A, 2000-08-15



<PAGE>

                            UNITED STATES
                 SECURITIES AND EXCHANGE COMMISSION
                        Washington, D.C.  20549

                              FORM 12b-25
                       NOTIFICATION OF LATE FILING

(Check one): ___  Form 10-KSB __ Form 20-F _X_ Form 10-QSB __ Form N-SAR
                                            -

            For period ended: June 30, 2000

            [ ] Transition Report on Form 10-K and Form 10-KSB
            [ ] Transition Report on Form 20-F
            [ ] Transition Report on Form 11-K
            [ ] Transition Report on Form 10-Q and Form 10-QSB
            [ ] Transition Report on Form N-SAR
            For the transition period ended

SEC File Number 0-23153

CUSIP Number -

Nothing  in this  form  shall be  construed  to imply  that the  Commission  has
verified any information contained herein.

If the notification  relates to a portion of the filing checked above,  identify
the item(s) to which the notification relates:__________________________________

                          PART I-REGISTRANT INFORMATION

VOLU-SOL, INC.
--------------------------------------
Full Name of Registrant

5099 West 2100 South
Salt Lake City, Utah 84120
(801) 974-9474
--------------------------------------
Address and telephone number of
principal executive office

                         PART II-RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or


<PAGE>



expense and the registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed. (Check appropriate box)

[ ]         (a) The reasons described in reasonable detail in Part III of this
            form could not be eliminated without unreasonable effort or expense;

[X]         (b) The subject annual report, semi-annual report, transition report
            on Forms 10-K, 10-KSB, 20-F, 11-K, or Form N-SAR, or portion thereof
            will be filed on or  before  the 15th  calendar  day  following  the
            prescribed due date; or the subject  quarterly  report or transition
            report on Form 10-Q,  10-QSB, or portion thereof will be filed on or
            before the fifth calendar day following the prescribed due date; and

[ ]         (c) The  accountant's  statement or other exhibit required by Rule
            12b-25(c) has been attached if applicable.


                              PART III-NARRATIVE

      State below in  reasonable  detail the reasons why the Form 10-K,  10-KSB,
11-K, 20-F 10-Q, 10-QSB,  N-SAR or the transition report portion thereof,  could
not be filed within the prescribed time period.

      The quarterly  report of the  registrant on Form 10-QSB could not be filed
      because  of delays  encountered  in  finalizing  the  financial  and other
      information needed to complete the report.

                          PART IV-OTHER INFORMATION

(1)   Name  and  telephone  number  of  person  to  contact  in  regard  to this
      notification.

W. Wilford Kirton III, CEO       (801)            974-9474
       (Name)                 (Area Code)    (Telephone Number)

(2)   Have all other periodic  reports required under Section 13 or 15(d) or the
      Securities  Exchange Act of 1934 or Section 30 of the  Investment  Company
      Act of 1940 during the  preceding  12 months (or for such  shorter  period
      that the registrant was required to file such  report(s))  been filed?  If
      the answer is no, identify report(s).
                                                               X  Yes    __ No

(3)   Is it  anticipated  that any  significant  change in results of operations
      from the corresponding period for the last fiscal year will be


<PAGE>


      reflected by the earnings statements to be included in the subject
      report or portion thereof?

                                                            __ Yes       X  No

            If so:  attach  an  explanation  of  the  anticipated  change,  both
            narratively  and  quantitatively,  and,  if  appropriate,  state the
            reasons why a reasonable estimate of the results cannot be made.



                                  VOLU-SOL, INC
                  (Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.



Date   August 14, 2000              By: /s/ Michael G. Acton
                                       ---------------------------------
                                       Michael G. Acton, Chief Financial Officer





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission